IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Quarter Est. Return
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$260M
AUM Growth
+$4.09M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
68
New
Increased
Reduced
Closed

Top Buys

1 +$12.6M
2 +$6.29M
3 +$5.4M
4
INCY icon
Incyte
INCY
+$3.55M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.01M

Top Sells

1 +$12.5M
2 +$4.3M
3 +$4.01M
4
GILD icon
Gilead Sciences
GILD
+$2.91M
5
BIIB icon
Biogen
BIIB
+$2.73M

Sector Composition

1 Healthcare 93.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
1
$16.1M 6.17%
163,500
+9,500
2
$15.1M 5.78%
189,522
-16,000
3
$14.1M 5.43%
83,222
+15,000
4
$12.6M 4.83%
+46,260
5
$11.6M 4.47%
694,500
-157,000
6
$10.8M 4.15%
31,330
-4,700
7
$10.5M 4.04%
36,208
-9,400
8
$10.1M 3.89%
81,641
+9,200
9
$9.57M 3.67%
444,534
+56,200
10
$9.55M 3.67%
370,000
11
$9.16M 3.52%
97,284
+32,000
12
$8.44M 3.24%
125,975
+53,000
13
$7.86M 3.02%
492,930
14
$7.25M 2.78%
56,105
-11,221
15
$7.23M 2.78%
428,633
+70,000
16
$6.73M 2.58%
42,996
-27,500
17
$6.4M 2.46%
90,284
-41,000
18
$6.29M 2.41%
+300,000
19
$5.4M 2.07%
+13,200
20
$5.27M 2.02%
126,500
21
$4.22M 1.62%
25,000
-74,000
22
$4.19M 1.61%
112,000
+75,000
23
$3.82M 1.47%
68,391
24
$3.62M 1.39%
36,800
25
$3.57M 1.37%
27,000